These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28410932)

  • 61. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
    Rios FG; Luna CM; Maskin B; Saenz Valiente A; Lloria M; Gando S; Sosa C; Baquero S; Llerena C; Petrati C; Apezteguia C
    Eur Respir J; 2007 Aug; 30(2):307-13. PubMed ID: 17504791
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
    Young DC; Zobell JT; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Jan; 48(1):1-7. PubMed ID: 22949160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Infection in burn patients in a referral center in Colombia.
    Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
    Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
    Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
    Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial activity of photodynamic therapy in combination with colistin against a pan-drug resistant Acinetobacter baumannii isolated from burn patient.
    Boluki E; Kazemian H; Peeridogaheh H; Alikhani MY; Shahabi S; Beytollahi L; Ghorbanzadeh R
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():1-5. PubMed ID: 28088439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ten years with colistin: a retrospective case series.
    Katz DE; Marchaim D; Assous MV; Yinnon A; Wiener-Well Y; Ben-Chetrit E
    Int J Clin Pract; 2016 Sep; 70(9):706-11. PubMed ID: 27291693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study.
    Reina R; Estenssoro E; Sáenz G; Canales HS; Gonzalvo R; Vidal G; Martins G; Das Neves A; Santander O; Ramos C
    Intensive Care Med; 2005 Aug; 31(8):1058-65. PubMed ID: 15983759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
    Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.
    Falagas ME; Kasiakou SK; Kofteridis DP; Roditakis G; Samonis G
    Eur J Clin Microbiol Infect Dis; 2006 Sep; 25(9):596-9. PubMed ID: 16955249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
    Dalfino L; Puntillo F; Mosca A; Monno R; Spada ML; Coppolecchia S; Miragliotta G; Bruno F; Brienza N
    Clin Infect Dis; 2012 Jun; 54(12):1720-6. PubMed ID: 22423120
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emergent renal dysfunction with colistin pharmacotherapy.
    Collins JM; Haynes K; Gallagher JC
    Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
    Garnacho-Montero J; Amaya-Villar R; Gutiérrez-Pizarraya A; Espejo-Gutiérrez de Tena E; Artero-González ML; Corcia-Palomo Y; Bautista-Paloma J
    Chemotherapy; 2013; 59(3):225-31. PubMed ID: 24356297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
    Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
    Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.
    Dersch R; Robinson E; Beume L; Rauer S; Niesen WD
    Neurol Sci; 2015 Apr; 36(4):633-4. PubMed ID: 25501805
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
    Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
    Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.
    Sadyrbaeva-Dolgova S; García-Fumero R; Exposito-Ruiz M; Pasquau-Liaño J; Jiménez-Morales A; Hidalgo-Tenorio C
    Sci Rep; 2022 Sep; 12(1):15261. PubMed ID: 36088407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.